FDA approved the Varipulse pulsed field ablation (PFA) platform for drug refractory paroxysmal atrial fibrillation, Johnson & ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

In a series of significant industry advancements, the U.S. FDA has given its nod to Johnson & Johnson's Varipulse device ...

Recent health news highlights include FDA approval for a Johnson & Johnson heart device, Canada's approval of Moderna's RSV ...

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...

The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

Johnson & Johnson received Food and Drug Administration approval for its Varipulse pulsed field ablation (PFA) system, ...